Meta Glasses for Low Vision

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

Visual impairment, particularly from glaucoma and retinal dystrophies, significantly hinders mobility and increases the risk of falls, leading to decreased independence and mental health challenges. Current low-vision assistive technologies primarily focus on near-task magnification for reading, leaving a critical gap in tools designed to assist with real-world navigation and peripheral vision loss. To address this, the proposed research evaluates Meta AI glasses, which offer real-time scene narration and object recognition, integrated with the Be My Eyes network. The study hypothesizes that this wearable AI technology will improve ambulation, orientation, and overall quality of life for patients, providing a functional solution for mobility that traditional devices lack.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Confirmed diagnosis of glaucoma, retinal dystrophy, or another condition associated with legal blindness.

Presence of documented irreversible vision loss

No surgical or laser procedures in the last 6 months

Visual field worse than 12db or poor visual acuity 20/400 or worse

Disqualifiers

Has no access to telephone

Unable to speak English

Has previously received comprehensive low vision services

Trial design

Design model

Single group

Treatments tested in this trial

  • Meta AI Glasses

    Other intervention

    Meta AI glasses in patients with low vision

  • Control

    Other intervention

    25 Patients will continue receiving standard care and will not receive the Meta AI glasses during the study period.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Meta AI GlassesExperimental treatment 1 intervention
Group B: ControlSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

patient-reported vision-targeted quality of life

The primary outcome will be change in patient-reported vision-targeted quality of life, measured using the National Eye Institute Visual Function Questionnaire - 25 item (NEI VFQ-25).

Time frame
4 weeks

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: